8-KOther Events

ABBOTT LABORATORIES 8-K Report (Apr 8, 2004)

Filed April 8, 2004For Securities:ABT

Summary

Abbott Laboratories (ABT) filed an 8-K on April 8, 2004, to report its first-quarter 2004 financial results. The filing includes a press release detailing operational performance, with a particular emphasis on non-GAAP financial measures. Management utilizes these adjusted figures, which exclude one-time charges, to offer investors a clearer view of the company's ongoing business performance and internal operational monitoring. Investors are encouraged to review these non-GAAP metrics alongside traditional GAAP-based financial statements. The company states that these adjusted figures are intended to provide additional context and allow for a better evaluation of underlying operational trends, separate from any unusual or unpredictable events that may impact reported earnings. The Chief Financial Officer, Thomas C. Freyman, signed the report, confirming the release of these results.

Key Highlights

  • 1Abbott Laboratories announced its first-quarter 2004 financial results on April 8, 2004.
  • 2The company filed a Form 8-K to report these results, primarily through an attached press release (Exhibit 99.1).
  • 3Abbott is providing non-GAAP financial measures, including adjusted net earnings, diluted earnings per share, and gross margin.
  • 4These non-GAAP measures exclude 'one-time charges' to better reflect ongoing business performance.
  • 5Management believes these adjusted figures offer valuable insights to investors for evaluating operational performance.
  • 6The company advises investors to consider these non-GAAP measures in addition to, and not as a substitute for, GAAP financial measures.
  • 7The filing was signed by Thomas C. Freyman, Executive Vice President, Finance and Chief Financial Officer.

Frequently Asked Questions

The main purpose of this 8-K filing is to announce Abbott Laboratories' financial results for the first quarter of 2004. It includes a press release that details these results and provides management's commentary.

Non-GAAP financial measures are financial metrics that are adjusted to exclude certain items, such as 'one-time charges,' which are considered unusual or unpredictable. Abbott is using them to provide investors with a view of the company's ongoing business performance, separate from any potentially distorting one-time events.

No, Abbott explicitly cautions investors to consider these non-GAAP financial measures in addition to, and not as a substitute for, financial measures prepared in accordance with Generally Accepted Accounting Principles (GAAP). GAAP figures provide the standard, audited financial picture.

The detailed financial results are primarily contained within the press release, furnished as Exhibit 99.1 to this 8-K filing. Investors should refer to this exhibit for specific figures.